| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
2 companies
Trigilio Jeffrey is a Chief Financial Officer at Cullinan Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 1 buy and 3 sells.
Estimated insider holdings value: $4.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 15, 2021 | CGEM Cullinan Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 8,000 | $25.00 | $200,000.00 | -78.0% | -46.6% | -49.5% | |
| Sep 8, 2021 | CGEM Cullinan Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 15,000 | $28.48 | $427,153.26 | -51.7% | -39.6% | -52.5% | |
| Jan 12, 2021 | CGEM Cullinan Therapeutics, Inc. | Chief Financial Officer | Buy | 2,250 | $21.00 | $47,250.00 | New | - | - |